Effects of a High Viscosity Dietary Fibre, as Part of a Medically Supervised Weight Management Program
NCT ID: NCT01387126
Last Updated: 2019-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE3
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Dietary Fibre Supplementation of a Low Calorie Diet on Appetite and Body Weight
NCT01109199
Effects of Fiber on Satiety
NCT01588600
A Very High Fiber Diet Versus a Low-carbohydrate Diet for Weight Loss
NCT01051674
Assessing the Dose Response of a Lead Fiber Snack Prototype
NCT04729816
Evaluation of Food Additive Contributions to Obesity - Feasibility Study 1
NCT03757962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Novel fibre supplement
The full dose of the study intervention is 15 grams per day.
Novel fibre supplement
The full dose of the study intervention is 15 grams per day.
Weight management program
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Novel fibre supplement
The full dose of the study intervention is 15 grams per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to provide written informed consent in accordance with Good Clinical Practice (GCP) and local legislation in English
Exclusion Criteria
* Type 2 diabetes on insulin treatment
* Contraindications to low calorie diet
* Any allergies to study product ingredients
* Any other medical, social or geographic condition, which, in the opinion of the investigator would not allow safe completion of the protocol.
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
InovoBiologic Inc.
INDUSTRY
Canadian Center for Functional Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael R Lyon, MD
Role: PRINCIPAL_INVESTIGATOR
Canadian Centre for Functional Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Canadian Centre for Functional Medicine
Coquitlam, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.